ADMA Biologics, Inc.

Go to ADMA Biologics, Inc. Website

$19.91

0.00 (0.00%)
Live
Previous Close

$19.91

Day Range

$0 - $0

Previous Day Range

$19.2812 - $20.2633

Market Cap

$4.6 billion USD

Day Vol.

0

Previous Day Vol.

2.6 million

Currency

USD

Primary Exchange

Nasdaq

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk fo...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

ADMA Biologics will report its second quarter 2025 financial results on August 6, 2025, after market close, with a conference call to discuss financial performance and company updates.

Related tickers: ADMA.

Read Full Article

Several mid-cap medical and biotechnology stocks have outperformed the broader market in 2025, including Penumbra Inc, TransMedics Group Inc, and ADMA Biologics Inc. These companies have shown strong momentum, bullish analyst sentiment, and potential for continued upside.

Related tickers: ADMA.

Read Full Article
Trending Tickers

Please sign in to view